It has been about a month since the last earnings report for Inogen (INGN). Shares have lost about 11.6% in that time frame, underperforming the S&P 500.

Inogen shows solid B2B growth, but guidance and margin issues hurt sentiment. Learn why INGN stock is a speculative play with long-term growth potential.

Inogen GAAP EPS of -$0.41 beats by $0.20, revenue of $80.1M beats by $6.2M Inogen targets $352M-$355M in 2025 revenue with focus on B2B growth and strategic innovations© Provided by Seeking Alpha ...

Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to ...

Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to ...

Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following investor ...

Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products widely available, allowing patients the chance to manage the ...

Nonetheless, his health after his nose injury is something the team will have to be extremely careful with to win its first Euros tournament since 2000. Soccer fans had so many amusing mask ideas ...

Inogen reported Q4 2023 revenues of $75.9 million, missing consensus. Despite challenges, the company's improvements position it well.

France captain Kylian Mbappe has revealed he feared his European Championship was over when he broke his nose in the opening game of the group stage. The Real Madrid forward suffered the injury in ...

Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to ...

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report first quarter 2025 financial ...